Sunitha Chari

BioSpace
As their name suggests, natural killer (NK) cells intrinsically recognize and kill stressed cells, such as cancer cells. NK cells are not a new approach to treating cancer, but a novel class of antibodies is giving them a leg up in the fight, and drugmakers, including 23andMe and Innate Pharma, are leveraging this approach to develop cell therapies for a range of cancers.
NK cells have a number of receptors that recognize specific stress ligands present on cancer cells, Lewis Lanier,...

Pictured: Cancer cells and IV bags over an abstract background/Taylor Tieden for BioSpace
As the oncology space moves away from single oncogene-targeted treatments, immunotherapies that aim to prevent immune fatigue and enhance immune cell engagement are emerging as promising therapeutic trends, experts told BioSpace. But these therapies are not always intended to be deployed on their own. Increasingly, scientists and clinicians are mixing and matching therapeutic strategies based on patient ...

Pictured: Resume being graded and shredded/Nicole Bean for BioSpace
It would likely come as news to no one in biopharma that the industry’s job market is currently a difficult one for candidates. “We are in a saturated job market, and navigating the job search process requires strategic thinking,” said Krystal Hicks, a career strategist and founder of the career counseling service Jobtalk. “Candidates have to stand out from the volume and position themselves as a great candidate.”
Oftentimes,...

AI in applicant tracking system

Use of psychometric tests in hiring

Pictured: Illustration including a brain, the Earth, a lock and other images/iStock, Bulgnn
AbbVie’s Humira, an injectable biologic for treating the symptoms of rheumatoid arthritis, is one of the best-selling drugs worldwide with over $20 billion in sales in 2022. Humira also stands out for a different reason: more ancillary patents have been filed for it with the U.S. Patent and Trademark Office (PTO) than for any other drug, according to a recent analysis. Such patents enable companies to ...